List of Tables
Table 1. Global Rapid Infectious Disease Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Influenza Test
Table 3. Key Players of Syphilis Test
Table 4. Key Players of AIDS Test
Table 5. Key Players of Other
Table 6. Global Rapid Infectious Disease Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Rapid Infectious Disease Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Rapid Infectious Disease Test Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Rapid Infectious Disease Test Market Share by Region (2020-2025)
Table 10. Global Rapid Infectious Disease Test Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Rapid Infectious Disease Test Market Share by Region (2026-2031)
Table 12. Rapid Infectious Disease Test Market Trends
Table 13. Rapid Infectious Disease Test Market Drivers
Table 14. Rapid Infectious Disease Test Market Challenges
Table 15. Rapid Infectious Disease Test Market Restraints
Table 16. Global Rapid Infectious Disease Test Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Rapid Infectious Disease Test Market Share by Players (2020-2025)
Table 18. Global Top Rapid Infectious Disease Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Infectious Disease Test as of 2024)
Table 19. Ranking of Global Top Rapid Infectious Disease Test Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Rapid Infectious Disease Test Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Rapid Infectious Disease Test, Headquarters and Area Served
Table 22. Global Key Players of Rapid Infectious Disease Test, Product and Application
Table 23. Global Key Players of Rapid Infectious Disease Test, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rapid Infectious Disease Test Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Rapid Infectious Disease Test Revenue Market Share by Type (2020-2025)
Table 27. Global Rapid Infectious Disease Test Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Rapid Infectious Disease Test Revenue Market Share by Type (2026-2031)
Table 29. Global Rapid Infectious Disease Test Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Rapid Infectious Disease Test Revenue Market Share by Application (2020-2025)
Table 31. Global Rapid Infectious Disease Test Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Rapid Infectious Disease Test Revenue Market Share by Application (2026-2031)
Table 33. North America Rapid Infectious Disease Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Rapid Infectious Disease Test Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Rapid Infectious Disease Test Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Rapid Infectious Disease Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Rapid Infectious Disease Test Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Rapid Infectious Disease Test Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Rapid Infectious Disease Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Rapid Infectious Disease Test Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Rapid Infectious Disease Test Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Rapid Infectious Disease Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Rapid Infectious Disease Test Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Rapid Infectious Disease Test Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Rapid Infectious Disease Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Rapid Infectious Disease Test Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Rapid Infectious Disease Test Market Size by Country (2026-2031) & (US$ Million)
Table 48. ELITech Group Company Details
Table 49. ELITech Group Business Overview
Table 50. ELITech Group Rapid Infectious Disease Test Product
Table 51. ELITech Group Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 52. ELITech Group Recent Development
Table 53. Fujirebio Company Details
Table 54. Fujirebio Business Overview
Table 55. Fujirebio Rapid Infectious Disease Test Product
Table 56. Fujirebio Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 57. Fujirebio Recent Development
Table 58. Medical Innovation Ventures Company Details
Table 59. Medical Innovation Ventures Business Overview
Table 60. Medical Innovation Ventures Rapid Infectious Disease Test Product
Table 61. Medical Innovation Ventures Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 62. Medical Innovation Ventures Recent Development
Table 63. Fago Medical Company Details
Table 64. Fago Medical Business Overview
Table 65. Fago Medical Rapid Infectious Disease Test Product
Table 66. Fago Medical Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 67. Fago Medical Recent Development
Table 68. Bio Group Medical System Company Details
Table 69. Bio Group Medical System Business Overview
Table 70. Bio Group Medical System Rapid Infectious Disease Test Product
Table 71. Bio Group Medical System Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 72. Bio Group Medical System Recent Development
Table 73. Association of Medicine and Analytics Company Details
Table 74. Association of Medicine and Analytics Business Overview
Table 75. Association of Medicine and Analytics Rapid Infectious Disease Test Product
Table 76. Association of Medicine and Analytics Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 77. Association of Medicine and Analytics Recent Development
Table 78. NanoEntek Company Details
Table 79. NanoEntek Business Overview
Table 80. NanoEntek Rapid Infectious Disease Test Product
Table 81. NanoEntek Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 82. NanoEntek Recent Development
Table 83. Shenzhen Medcaptain Medical Technology Company Details
Table 84. Shenzhen Medcaptain Medical Technology Business Overview
Table 85. Shenzhen Medcaptain Medical Technology Rapid Infectious Disease Test Product
Table 86. Shenzhen Medcaptain Medical Technology Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 87. Shenzhen Medcaptain Medical Technology Recent Development
Table 88. Nanjing Liming Bio-products Company Details
Table 89. Nanjing Liming Bio-products Business Overview
Table 90. Nanjing Liming Bio-products Rapid Infectious Disease Test Product
Table 91. Nanjing Liming Bio-products Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 92. Nanjing Liming Bio-products Recent Development
Table 93. Tianjin Era Biology Techology Company Details
Table 94. Tianjin Era Biology Techology Business Overview
Table 95. Tianjin Era Biology Techology Rapid Infectious Disease Test Product
Table 96. Tianjin Era Biology Techology Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 97. Tianjin Era Biology Techology Recent Development
Table 98. Beijing Baicare Biotechnology Company Details
Table 99. Beijing Baicare Biotechnology Business Overview
Table 100. Beijing Baicare Biotechnology Rapid Infectious Disease Test Product
Table 101. Beijing Baicare Biotechnology Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 102. Beijing Baicare Biotechnology Recent Development
Table 103. Wuxi BioTeke Corporation Company Details
Table 104. Wuxi BioTeke Corporation Business Overview
Table 105. Wuxi BioTeke Corporation Rapid Infectious Disease Test Product
Table 106. Wuxi BioTeke Corporation Revenue in Rapid Infectious Disease Test Business (2020-2025) & (US$ Million)
Table 107. Wuxi BioTeke Corporation Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Rapid Infectious Disease Test Picture
Figure 2. Global Rapid Infectious Disease Test Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rapid Infectious Disease Test Market Share by Type: 2024 VS 2031
Figure 4. Influenza Test Features
Figure 5. Syphilis Test Features
Figure 6. AIDS Test Features
Figure 7. Other Features
Figure 8. Global Rapid Infectious Disease Test Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Rapid Infectious Disease Test Market Share by Application: 2024 VS 2031
Figure 10. Workplace Testing Case Studies
Figure 11. Hospital Testing Case Studies
Figure 12. Other Testing Case Studies
Figure 13. Rapid Infectious Disease Test Report Years Considered
Figure 14. Global Rapid Infectious Disease Test Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Rapid Infectious Disease Test Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Rapid Infectious Disease Test Market Share by Region: 2024 VS 2031
Figure 17. Global Rapid Infectious Disease Test Market Share by Players in 2024
Figure 18. Global Top Rapid Infectious Disease Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Infectious Disease Test as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Rapid Infectious Disease Test Revenue in 2024
Figure 20. North America Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Rapid Infectious Disease Test Market Share by Country (2020-2031)
Figure 22. United States Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Rapid Infectious Disease Test Market Share by Country (2020-2031)
Figure 26. Germany Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Rapid Infectious Disease Test Market Share by Region (2020-2031)
Figure 34. China Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Rapid Infectious Disease Test Market Share by Country (2020-2031)
Figure 42. Mexico Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Rapid Infectious Disease Test Market Share by Country (2020-2031)
Figure 46. Turkey Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Rapid Infectious Disease Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. ELITech Group Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 50. Fujirebio Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 51. Medical Innovation Ventures Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 52. Fago Medical Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 53. Bio Group Medical System Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 54. Association of Medicine and Analytics Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 55. NanoEntek Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 56. Shenzhen Medcaptain Medical Technology Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 57. Nanjing Liming Bio-products Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 58. Tianjin Era Biology Techology Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 59. Beijing Baicare Biotechnology Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 60. Wuxi BioTeke Corporation Revenue Growth Rate in Rapid Infectious Disease Test Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed